Primary malignancy in patients undergoing immunosuppression for renal transplantation

Transplantation. 1969 Aug;8(2):209-12. doi: 10.1097/00007890-196908000-00033.
No abstract available

MeSH terms

  • Adult
  • Carcinoma / chemically induced
  • Carcinoma / epidemiology
  • Carcinoma, Squamous Cell / chemically induced
  • Carcinoma, Squamous Cell / epidemiology
  • Dysgerminoma / chemically induced
  • Dysgerminoma / epidemiology
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Kidney Transplantation*
  • Leukemia / chemically induced
  • Leukemia / epidemiology
  • Lymphoma, Large B-Cell, Diffuse / chemically induced
  • Lymphoma, Large B-Cell, Diffuse / epidemiology
  • Lymphoma, Non-Hodgkin / chemically induced
  • Lymphoma, Non-Hodgkin / epidemiology
  • Male
  • Neoplasms / chemically induced*
  • Neoplasms / epidemiology*
  • Plasmacytoma / chemically induced
  • Plasmacytoma / epidemiology

Substances

  • Immunosuppressive Agents